TSST-1 induces Th1 or Th2 differentiation in naive CD4+T cells in a dose- and APC-dependent manner

被引:13
作者
Brandt, K [1 ]
Van der Bosch, J [1 ]
Fliegert, R [1 ]
Gehring, S [1 ]
机构
[1] Med Clin Res Ctr Borstel, Div Expt Immunopharmacol, D-23845 Borstel, Germany
关键词
D O I
10.1046/j.1365-3083.2002.01170.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Superantigens are potent activators of the immune system, causing a variety of diseases, ranging from food poisoning to septic shock. Here, we examined the effects of different toxic shock syndrome toxin 1 (TSST-1) concentrations on the activation, proliferation and synthesis of interferon-gamma (IFN-gamma) and interleukin-4 (IL-4) in purified naive human CD4(+) T cells in a serum-free in vitro system. TSST-1 given in low doses (1-10 pg/ml) generates a pronounced T helper 2 (Th2)-like cytokine profile, characterized by elevated IL-4-expressing T-cell populations and reduced IFN-gamma-producing populations, whereas higher doses (100 pg/ml) induce a Th1-like profile, with increased expression of IFN-gamma and reduced expression of IL-4. These patterns were even more pronounced by adding exogenous cytokines like IL-12 and IL-4 and by the type of antigen-presenting cells (APCs). Thus, B cells induced Th2 shifts, whereas monocytes favoured Th1 induction. Moreover, IL-12 in conditions with B cells counteracted their Th2 bias. Interestingly, in purified naive T-cell cultures, containing a small population of HLA-DR+ T cells, Th1/Th2 differentiation can be induced by TSST-1 too. There, Th-cell polarization is strongly dependent on TSST-1 concentration, indicating that this is a key parameter in regulating the differentiation of T cells. In conclusion, our data show that Th1/Th2 differentiation of TSST-1-stimulated naive T cells is controlled by the type of APCs, and in APC-depleted cultures, it depends on the presence of HLA-DR+ cells and TSST-1 concentration.
引用
收藏
页码:572 / 579
页数:8
相关论文
共 32 条
[1]   T cell responses are governed by avidity and co-stimulatory thresholds [J].
Bachmann, MF ;
Sebzda, E ;
Kundig, TM ;
Shahinian, A ;
Speiser, DE ;
Mak, TW ;
Ohashi, PS .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1996, 26 (09) :2017-2022
[2]  
Blotta MH, 1997, J IMMUNOL, V158, P5589
[3]   Costimulation light:: Activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile [J].
Broeren, CPM ;
Gray, GS ;
Carreno, BM ;
June, CH .
JOURNAL OF IMMUNOLOGY, 2000, 165 (12) :6908-6914
[4]   Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis [J].
Bunikowski, R ;
Mielke, MEA ;
Skarabis, H ;
Worm, M ;
Anagnostopoulos, I ;
Kolde, G ;
Wahn, U ;
Renz, H .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (04) :814-819
[5]  
Cameron SB, 2001, EUR CYTOKINE NETW, V12, P210
[6]   BEE VENOM PHOSPHOLIPASE-A2-SPECIFIC T-CELL CLONES FROM HUMAN ALLERGIC AND NONALLERGIC INDIVIDUALS - CYTOKINE PATTERNS CHANGE IN RESPONSE TO THE ANTIGEN CONCENTRATION [J].
CARBALLIDO, JM ;
CARBALLIDOPERRIG, N ;
TERRES, G ;
HEUSSER, CH ;
BLASER, K .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (06) :1357-1363
[7]   SELECTIVE EXPANSION OF T-CELLS EXPRESSING V-BETA-2 IN TOXIC SHOCK SYNDROME [J].
CHOI, YW ;
LAFFERTY, JA ;
CLEMENTS, JR ;
TODD, JK ;
GELFAND, EW ;
KAPPLER, J ;
MARRACK, P ;
KOTZIN, BL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 172 (03) :981-984
[8]   EXTENT OF T-CELL RECEPTOR LIGATION CAN DETERMINE THE FUNCTIONAL-DIFFERENTIATION OF NAIVE CD4(+) T-CELLS [J].
CONSTANT, S ;
PFEIFFER, C ;
WOODARD, A ;
PASQUALINI, T ;
BOTTOMLY, K .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (05) :1591-1596
[9]   Staphylococcal toxin-induced T cell proliferation in atopic eczema correlates with increased use of superantigen-reactive Vβ-chains in cutaneous lymphocyte-associated antigen (CLA)-positive lymphocytes [J].
Davison, S ;
Allen, M ;
Vaughan, R ;
Barker, J .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 121 (02) :181-186
[10]   Maturation of human neonatal CD4+ and CD8+ T lymphocytes into Th1/Th2 effectors [J].
Delespesse, G ;
Yang, LP ;
Ohshima, Y ;
Demeure, C ;
Shu, U ;
Byun, DG ;
Sarfati, M .
VACCINE, 1998, 16 (14-15) :1415-1419